{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:58:24Z","timestamp":1791295104537,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2021JJ40976"],"award-info":[{"award-number":["2021JJ40976"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102803"],"award-info":[{"award-number":["82102803"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272849"],"award-info":[{"award-number":["82272849"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","award":["202002024"],"award-info":[{"award-number":["202002024"]}],"id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.heliyon.2023.e21387","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T11:35:19Z","timestamp":1697888119000},"page":"e21387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics, outcomes, and risk factors of SARS-CoV-2 breakthrough infections among 572 fully vaccinated (BBIBP-CorV) hospitalized patients"],"prefix":"10.1016","volume":"9","author":[{"given":"Yihuang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4424-9727","authenticated-orcid":false,"given":"Guangtong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e21387_bib1","series-title":"Weekly Epidemiological Update on COVID-19 - 22 March","year":"2023"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21387_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","article-title":"Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review","volume":"28","author":"Fiolet","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"issue":"23","key":"10.1016\/j.heliyon.2023.e21387_bib4","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1056\/NEJMoa2105000","article-title":"Vaccine breakthrough infections with SARS-CoV-2 variants","volume":"384","author":"Hacisuleyman","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10325","key":"10.1016\/j.heliyon.2023.e21387_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0140-6736(22)00090-3","article-title":"Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose","volume":"399","author":"Kuhlmann","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21387_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41577-021-00662-4","article-title":"SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact","volume":"22","author":"Lipsitch","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21387_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41591-022-02138-x","article-title":"Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave","volume":"29","author":"Tan","year":"2023","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21387_bib8","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/jmv.27636","article-title":"Genomic, immunological, and clinical analysis of COVID-19 vaccine breakthrough infections in Beijing, China","volume":"94","author":"Tian","year":"2022","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21387_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.heliyon.2023.e21387_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1049393","article-title":"Risk of hospitalization and vaccine effectiveness among COVID-19 patients in the UAE during the Delta and Omicron outbreaks","volume":"14","author":"Albreiki","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e21387_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278546","article-title":"Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco","volume":"17","author":"Belayachi","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e21387_bib12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijid.2022.12.024","article-title":"Effectiveness of COVID-19 vaccines on hospitalization and death in Guilan, Iran: a test-negative case-control study","volume":"128","author":"Heidarzadeh","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e21387_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101981","article-title":"Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study","volume":"59","author":"Sun","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21387_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","volume":"146","author":"Li","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.heliyon.2023.e21387_bib15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.psychres.2018.10.073","article-title":"Factors predicting re-hospitalization for inpatients with bipolar mania--A naturalistic cohort","volume":"270","author":"Li","year":"2018","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.heliyon.2023.e21387_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.psychres.2016.08.065","article-title":"Neurocognition in help-seeking individuals at risk for psychosis: prediction of outcome after 24 months","volume":"246","author":"Metzler","year":"2016","journal-title":"Psychiatr. Res."},{"issue":"10326","key":"10.1016\/j.heliyon.2023.e21387_bib17","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(21)02346-1","article-title":"Diagnostics for COVID-19: moving from pandemic response to control","volume":"399","author":"Peeling","year":"2022","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.heliyon.2023.e21387_bib18","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.2021.3199","article-title":"SARS-CoV-2 vaccines effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial","volume":"325","author":"Creech","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21387_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1473-3099(21)00462-X","article-title":"Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1\/2 trial","volume":"22","author":"Xia","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"10267","key":"10.1016\/j.heliyon.2023.e21387_bib20","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e21387_bib21","doi-asserted-by":"crossref","first-page":"830","DOI":"10.7326\/M20-6841","article-title":"COVID-19 vaccine: what physicians need to know","volume":"173","author":"Laine","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"7923","key":"10.1016\/j.heliyon.2023.e21387_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","article-title":"Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5","volume":"608","author":"Wang","year":"2022","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.heliyon.2023.e21387_bib23","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21387_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.5755","article-title":"Transmission characteristics and inactivated vaccine effectiveness against transmission of SARS-CoV-2 omicron BA.5 variants in urumqi, China","volume":"6","author":"Wang","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e21387_bib25","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1473-3099(23)00199-8","article-title":"Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged \u226518 years: a randomised, double-blind, phase 2b trial","volume":"23","author":"Wu","year":"2023","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e21387_bib26","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/jmv.25930","article-title":"Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test","volume":"92","author":"Xie","year":"2020","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21387_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e21387_bib28","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"issue":"10229","key":"10.1016\/j.heliyon.2023.e21387_bib29","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.heliyon.2023.e21387_bib30","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the lombardy region","volume":"323","author":"Grasselli","year":"2020","journal-title":"Italy, JAMA."},{"key":"10.1016\/j.heliyon.2023.e21387_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105400","article-title":"Increasing the frequency of omicron variant mutations boosts the immune response and may reduce the virus virulence","volume":"164","author":"Dawood","year":"2022","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21387_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13054-020-02902-w","article-title":"Clinical determinants for fatality of 44,672 patients with COVID-19","volume":"24","author":"Deng","year":"2020","journal-title":"Crit. Care"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21387_bib33","first-page":"400","article-title":"Can we predict the severity of coronavirus disease 2019 with a routine blood test?","volume":"130","author":"Zeng","year":"2020","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.heliyon.2023.e21387_bib34","article-title":"Clinical significance of plasma D-dimer in COVID-19 mortality","volume":"8","author":"Li","year":"2021","journal-title":"Front. Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402308595X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402308595X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:10:28Z","timestamp":1791292228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402308595X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S240584402308595X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21387","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics, outcomes, and risk factors of SARS-CoV-2 breakthrough infections among 572 fully vaccinated (BBIBP-CorV) hospitalized patients","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e21387"}}